The advanced lung cancer inflammation index predicts outcomes in patients with Crohn's disease after surgical resection.
Crohn's disease
advanced lung cancer inflammation index
inflammation
nutrition
prognosis
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
05
03
2020
accepted:
25
06
2020
pubmed:
10
7
2020
medline:
19
8
2021
entrez:
10
7
2020
Statut:
ppublish
Résumé
Precise biomarkers for predicting prognosis could help to identify high-risk Crohn's disease (CD) patients to facilitate better follow-up during the postoperative course. In this study, the primary aim is the identification of the most reliable nutrition marker that predicts surgical relapse in CD patients. We first evaluated the predictive value of various nutrition markers for postoperative surgical relapse in CD patients and identified the advanced lung cancer inflammation index (ALI) as a promising biomarker. Then, we assessed the clinical significance of preoperative ALI in CD patients using two cohorts. Preoperative ALI showed the highest correlation with reoperation rate compared with other nutritional parameters in CD patients receiving surgical resection (sensitivity 53%, specificity 86%, area under the curve 0.71). Lower levels of preoperative ALI were significantly correlated with the presence of perianal disease. A lower level of preoperative ALI was an independent prognostic factor for reoperation rate after an intestinal resection (hazard ratio 3.37, 95% CI 1.38-10.12, P = 0.006), and the prognostic impact of preoperative ALI was successfully validated in an independent cohort using the same cut-off value. Preoperative ALI might be useful for postoperative management of CD patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
84-93Informations de copyright
© 2020 Association of Coloproctology of Great Britain and Ireland.
Références
Lewis RT, Maron DJ. Efficacy and complications of surgery for Crohn's disease. Gastroenterol Hepatol 2010; 6: 587-96.
Gklavas A, Dellaportas D, Papaconstantinou I. Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors. Ann Gastroenterol 2017; 30: 598-612.
Fornaro R, Caratto E, Caratto M et al. Post-operative recurrence in Crohn's disease. Critical analysis of potential risk factors. An update. Surgeon 2015; 13: 330-47.
Araki T, Okita Y, Kondo S et al. Risk factors for recurrence of Crohn's disease requiring surgery in patients receiving post-operative anti-tumor necrosis factor maintenance therapy. J Anus Rectum Colon 2017; 1: 15-21.
Regueiro M, Velayos F, Greer JB et al. American Gastroenterological Association Institute technical review on the management of Crohn's disease after surgical resection. Gastroenterology 2017; 152: 277-95. e3.
Comeche JM, Caballero P, Gutierrez-Hervas A et al. Enteral nutrition in patients with inflammatory bowel disease. Systematic review, meta-analysis, and meta-regression. Nutrients 2019; 11: 2657.
Hirai F, Takeda T, Takada Y et al. Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis. J Gastroenterol 2020; 55: 133-41.
Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn's disease: a review. World J Gastroenterol 2013; 19: 7652-60.
Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007; 25: 67-72.
Wang H, Zuo L, Zhao J et al. Impact of preoperative exclusive enteral nutrition on postoperative complications and recurrence after bowel resection in patients with active Crohn's disease. World J Surg 2016; 40: 1993-2000.
Okugawa Y, Toiyama Y, Yamamoto A et al. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer. Clin Nutr 2020; 39: 1209-17.
Okugawa Y, Toiyama Y, Yamamoto A et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 2019.
Yamamoto A, Toiyama Y, Okugawa Y et al. Clinical implications of pretreatment: lymphocyte-to-monocyte ratio in patients with rectal cancer receiving preoperative chemoradiotherapy. Dis Colon Rectum 2019; 62: 171-80.
Toiyama Y, Oki S, Okugawa Y et al. Clinical impact of preoperative albumin-globulin ratio in patients with rectal cancer treated with preoperative chemoradiotherapy. Oncology 2018; 95: 270-80.
Okugawa Y, Toiyama Y, Oki S et al. Feasibility of assessing prognostic nutrition index in patients with rectal cancer who receive preoperative chemoradiotherapy. J Parenter Enteral Nutr 2018; 42: 998-1007.
Okugawa Y, Toiyama Y, Yamamoto A et al. Clinical impact of muscle quantity and quality in colorectal cancer patients: a propensity score matching analysis. J Parenter Enteral Nutr 2018; 42: 1322-33.
Okugawa Y, Toiyama Y, Yamamoto A et al. Close relationship between immunological/inflammatory markers and myopenia and myosteatosis in patients with colorectal cancer: a propensity score matching analysis. J Parenter Enteral Nutr 2019; 43: 508-15.
Okugawa Y, Toiyama Y, Hur K et al. Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients. J Cachexia Sarcopenia Muscle 2019; 10: 536-48.
Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer 2013; 13: 158.
Kim EY, Kim N, Kim YS et al. Prognostic significance of modified advanced lung cancer inflammation index (ALI) in patients with small cell lung cancer - comparison with original ALI. PLoS One 2016; 11: e0164056.
Adachi T, Hinoi T, Kinugawa Y et al. Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer. J Gastroenterol 2016; 51: 779-87.
Hamaguchi Y, Kaido T, Okumura S et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 2014; 20: 1413-9.
Okumura S, Kaido T, Hamaguchi Y et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157: 1088-98.
Bamba S, Sasaki M, Takaoka A et al. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease. PLoS One 2017; 12: e0180036.
Onodera T, Goseki N. Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi 1984; 85: 1001-5.
Okita Y, Araki T, Okugawa Y et al. The prognostic nutritional index for postoperative infectious complication in patients with ulcerative colitis undergoing proctectomy with ileal pouch-anal anastomosis following subtotal colectomy. J Anus Rectum Colon 2019; 3: 91-7.
Horio Y, Uchino M, Bando T, Chohno T, Takesue Y, Ikeuchi H. Association between higher body mass index and pouch-related complications during restorative proctocolectomy in patients with ulcerative colitis. Digestion 2018; 98: 257-62.
Chohno T, Uchino M, Sasaki H, Bando T, Takesue Y, Ikeuchi H. Associations between the prognostic nutritional index and morbidity/mortality during intestinal resection in patients with ulcerative colitis. World J Surg 2018; 42: 1949-59.
Zhang J, Xu L, Li J et al. Gender differences in the association between body mass index and health-related quality of life among adults:a cross-sectional study in Shandong, China. BMC Public Health 2019; 19: 1021.
De Cruz P, Kamm MA, Hamilton AL et al. Crohn's disease management after intestinal resection: a randomised trial. Lancet 2015; 385: 1406-17.
Kusaka J, Shiga H, Kuroha M et al. Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease. Int J Colorectal Dis 2017; 32: 1407-13.
Shimada N, Ohge H, Kono T et al. Surgical recurrence at anastomotic site after bowel resection in Crohn's disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 2019; 23: 312-9.
Hua X, Chen J, Wu Y, Sha J, Han S, Zhu X. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis. World J Surg Oncol 2019; 17: 177.
Shibutani M, Maeda K, Nagahara H et al. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study. BMC Cancer 2019; 19: 241.
He X, Zhou T, Yang Y et al. Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer. Clin Lung Cancer 2015; 16: e165-e171.
Feng JF, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther 2014; 7: 1811-5.
Ge X, Tang S, Yang X et al. The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn's disease: a cohort study. Int J Surg 2019; 65: 39-44.
Frolkis AD, Lipton DS, Fiest KM et al. Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol 2014; 109: 1739-48.